Literature DB >> 32529512

Sugar and artificially sweetened beverages and risk of obesity, type 2 diabetes mellitus, hypertension, and all-cause mortality: a dose-response meta-analysis of prospective cohort studies.

Pei Qin1, Quanman Li1,2, Yang Zhao3, Qing Chen4, Xizhuo Sun2, Yu Liu2, Honghui Li2, Tieqiang Wang5, Xiaoliang Chen5, Qionggui Zhou1, Chunmei Guo2, Dongdong Zhang2, Gang Tian2, Dechen Liu2, Ranran Qie2, Minghui Han4, Shengbing Huang4, Xiaoyan Wu4, Yang Li1, Yifei Feng2, Xingjin Yang2, Fulan Hu1,2, Dongsheng Hu1,2,3, Ming Zhang6.   

Abstract

Although consumption of sugar-sweetened beverages (SSBs) and artificially sweetened beverages (ASBs) has increasingly been linked with obesity, type 2 diabetes mellitus, hypertension, and all-cause mortality, evidence remains conflicted and dose-response meta-analyses of the associations are lacking. We conducted an updated meta-analysis to synthesize the knowledge about their associations and to explore their dose-response relations. We comprehensively searched PubMed, EMBASE, Web of Science, and Open Grey up to September 2019 for prospective cohort studies investigating the associations in adults. Summary relative risks (RRs) and 95% confidence intervals (CIs) were estimated for the dose-response association. Restricted cubic splines were used to evaluate linear/non-linear relations. We included 39 articles in the meta-analysis. For each 250-mL/d increase in SSB and ASB intake, the risk increased by 12% (RR = 1.12, 95% CI 1.05-1.19, I2 = 67.7%) and 21% (RR = 1.21, 95% CI 1.09-1.35, I2 = 47.2%) for obesity, 19% (RR = 1.19, 95% CI 1.13-1.25, I2 = 82.4%) and 15% (RR = 1.15, 95% CI 1.05-1.26, I2 = 92.6%) for T2DM, 10% (RR = 1.10, 95% CI 1.06-1.14, I2 = 58.4%) and 8% (RR = 1.08, 95% CI 1.06-1.10, I2 = 24.3%) for hypertension, and 4% (RR = 1.04, 95% CI 1.01-1.07, I2 = 58.0%) and 6% (RR = 1.06, 95% CI 1.02-1.10, I2 = 80.8%) for all-cause mortality. For SSBs, restricted cubic splines showed linear associations with risk of obesity (Pnon-linearity = 0.359), T2DM (Pnon-linearity = 0.706), hypertension (Pnon-linearity = 0.510) and all-cause mortality (Pnon-linearity = 0.259). For ASBs, we found linear associations with risk of obesity (Pnon-linearity = 0.299) and T2DM (Pnon-linearity = 0.847) and non-linear associations with hypertension (Pnon-linearity = 0.019) and all-cause mortality (Pnon-linearity = 0.048). Increased consumption of SSBs and ASBs is associated with risk of obesity, T2DM, hypertension, and all-cause mortality. However, the results should be interpreted cautiously because the present analyses were based on only cohort but not intervention studies.

Entities:  

Keywords:  All-cause mortality; Hypertension; Meta-analysis; Obesity; Prospective cohort studies; Sweetened beverages; Type 2 diabetes mellitus

Mesh:

Substances:

Year:  2020        PMID: 32529512     DOI: 10.1007/s10654-020-00655-y

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  21 in total

1.  Consumption of sugar-sweetened soft drinks and risk of metabolic syndrome and its components: results of the ELSA-Brasil study (2008-2010 and 2012-2014).

Authors:  J H Siqueira; T S Silva Pereira; A D Moreira; M F H S Diniz; G Velasquez-Melendez; M J M Fonseca; S M Barreto; I M Benseñor; J G Mill; M C B Molina
Journal:  J Endocrinol Invest       Date:  2022-08-13       Impact factor: 5.467

2.  Sugary drink consumption and the subsequent risk of gastric cancer: The Japan Public Health Center-based Prospective Study.

Authors:  Paramita Khairan; Tomotaka Sobue; Ehab Salah Eshak; Tetsuhisa Kitamura; Motoki Iwasaki; Manami Inoue; Taiki Yamaji; Hiroyasu Iso; Shoichiro Tsugane; Norie Sawada
Journal:  Eur J Clin Nutr       Date:  2022-09-27       Impact factor: 4.884

3.  Association of sweetened beverages consumption with all-cause mortality risk among Dutch adults: the Lifelines Cohort Study (the SWEET project).

Authors:  Novita D Naomi; Elske M Brouwer-Brolsma; Marion E C Buso; Sabita S Soedamah-Muthu; Joanne A Harrold; Jason C G Halford; Anne Raben; Johanna M Geleijnse; Edith J M Feskens
Journal:  Eur J Nutr       Date:  2022-10-21       Impact factor: 4.865

4.  Sugar-sweetened beverage intake in adulthood and adolescence and risk of early-onset colorectal cancer among women.

Authors:  Kana Wu; Edward Giovannucci; Yin Cao; Jinhee Hur; Ebunoluwa Otegbeye; Hee-Kyung Joh; Katharina Nimptsch; Kimmie Ng; Shuji Ogino; Jeffrey A Meyerhardt; Andrew T Chan; Walter C Willett
Journal:  Gut       Date:  2021-05-06       Impact factor: 23.059

5.  Consumption of sugar-sweetened and artificially sweetened beverages and breast cancer survival.

Authors:  Maryam S Farvid; Nicholas D Spence; Bernard A Rosner; Wendy Y Chen; A Heather Eliassen; Walter C Willett; Michelle D Holmes
Journal:  Cancer       Date:  2021-05-04       Impact factor: 6.921

6.  Exploring diet associations with Covid-19 and other diseases: a Network Analysis-based approach.

Authors:  Rashmeet Toor; Inderveer Chana
Journal:  Med Biol Eng Comput       Date:  2022-02-16       Impact factor: 3.079

7.  Identifying the latent classes of modifiable risk behaviours among diabetic and hypertensive individuals in Northeastern India: a population-based cross-sectional study.

Authors:  Strong P Marbaniang; Hemkhothang Lhungdim; Holendro Singh Chungkham
Journal:  BMJ Open       Date:  2022-02-24       Impact factor: 2.692

8.  The Dose-Response Associations of Sugar-Sweetened Beverage Intake with the Risk of Stroke, Depression, Cancer, and Cause-Specific Mortality: A Systematic Review and Meta-Analysis of Prospective Studies.

Authors:  Yuanxin Wang; Renqing Zhao; Bin Wang; Chen Zhao; Baishu Zhu; Xin Tian
Journal:  Nutrients       Date:  2022-02-12       Impact factor: 5.717

9.  Effect of excise tax on sugar-sweetened beverages in Catalonia, Spain, three and a half years after its introduction.

Authors:  Miguel Ángel Royo-Bordonada; Carlos Fernández-Escobar; Carlos José Gil-Bellosta; Elena Ordaz
Journal:  Int J Behav Nutr Phys Act       Date:  2022-03-12       Impact factor: 6.457

10.  Artificial sweeteners and cancer risk: Results from the NutriNet-Santé population-based cohort study.

Authors:  Charlotte Debras; Eloi Chazelas; Bernard Srour; Nathalie Druesne-Pecollo; Younes Esseddik; Fabien Szabo de Edelenyi; Cédric Agaësse; Alexandre De Sa; Rebecca Lutchia; Stéphane Gigandet; Inge Huybrechts; Chantal Julia; Emmanuelle Kesse-Guyot; Benjamin Allès; Valentina A Andreeva; Pilar Galan; Serge Hercberg; Mélanie Deschasaux-Tanguy; Mathilde Touvier
Journal:  PLoS Med       Date:  2022-03-24       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.